Outpatient Surgery Magazine

2020 Big Book of Surgery

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/1191482

Contents of this Issue

Navigation

Page 42 of 71

D E C E M B E R 2 0 1 9 • B I G B O O K O F S U R G E R Y. C O M • 4 3 OMIDRIA ® (Phenylephrine and Ketorolac Intraocular Solution) 1% / 0.3% OMIDRIA ® is the first and only FDA-approved NSAID- containing product for intraocular use during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative pain. How is OMIDRIA ® used during surgery? • Added preoperatively to irrigating solution, OMIDRIA ® is easy to integrate into routine operating procedures; • Continuous delivery of OMIDRIA ® in the irrigation solution provides steady-state concentrations of NSAID and phenylephrine at the site of surgery; • Preoperatively, add one 4-mL single-patient-use vial to 500 mL ophthalmic irrigating solution. For more information, visit www.omidria.com These Scalpels Boost Your Cataract Economics Produce great outcomes and excellent profitability with resposable Micro Feather scalpels, available from Oasis Medical. Feather scalpels feature an ultra-sharp blade and a lightweight aluminum handle with a textured grip for maximum control. Available in more than 10 widths, five scalpels per box. They come with sterile, individual autoclavable cases. Also check out VISCO SHIELD Topical Drops. This preservative- free lubricant helps keep the cornea hydrated during ocular surgery. Each box comes with six, 2.0mL pre-filled syringes with cannula. For more information, call (844) 820-8940, email Treat Osteochondral Lesions With This Innovative Technique Enhance subchondral bone marrow lesion treatment outcomes using the IntraOsseous Bioplasty ® (IOBP) technique. It's a biologic surgical procedure used for bone pathologies resulting from acute or chronic injury, including bone marrow lesions and spontaneous knee osteonecrosis. Arthrex offers options for the treatment of these pathologies using its Angel ® platelet-rich plasma concentrate (cPRP) and bone marrow processing system. Perform a core decompression of the lesion and a direct application of customized cPRP from bone marrow aspirate with a proprietary platelet sensor and one-button automation. The IOBP ® encourages physiologic bone remodeling and repair. For more information, visit Ad.Arthrex.com/IOBP FOR MORE INFORMATION ON THESE PRODUCTS, EMAIL GETINFO@OUTPATIENTSURGERY.NET (SEE PAGE 3) OR VISIT BIGBOOKOFSURGERY.COM O R T H O P E D I C S

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - 2020 Big Book of Surgery